Comment Now: Increase Latino Representation in Alzheimer’s Clinical Trials!

The National Institute of Aging (NIA) is seeking comments and suggestions on how it can implement community-based research networks to increase diversity in clinical trials for Alzheimer’s disease and related dementias (ADRD). At Salud America!, we believe that diverse representation is critical in Alzheimer's clinical trials to ensure that health and medical discoveries are equitable for diverse populations. This means increasing diversity among research leaders and clinical trial participants and establishing sustainable connections with Latino communities and other communities of color who have historically been underrepresented in medicine. If you agree, you can endorse Dr. Amelie Ramirez’s comment to NIA. Responses will be accepted through Saturday April 9, ...
Read More